Development of cytomegalovirus resistant to maribavir: real world, real problem?

Transpl Infect Dis. 2024 Apr;26(2):e14259. doi: 10.1111/tid.14259. Epub 2024 Mar 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Cytomegalovirus Infections* / drug therapy
  • Cytomegalovirus*
  • Dichlororibofuranosylbenzimidazole / analogs & derivatives*
  • Drug Resistance, Viral
  • Humans

Substances

  • maribavir
  • Antiviral Agents
  • Dichlororibofuranosylbenzimidazole